Heterogeneity and efficacy of immunotherapy in multiple cancer: insights from a meta-analysis
This meta-analysis provides valuable insights into the potential of immunotherapy, particularly CAR-T, in cancer treatment. Findings showed the different efficacy and safety of immunotherapy in treating multiple cancers, with various objective response rates. Continued studies from more trials with different populations are needed to optimize their efficacy in further cancer treatment and precision medicine.
Authors
- Xia Xue (ORCID: https://orcid.org/0000-0002-5783-1281)
- Pengya Feng
- Bin Liu (ORCID: https://orcid.org/0000-0002-1896-6941)
- Xiaojuan Zhang (ORCID: https://orcid.org/0000-0002-9932-3939)
- Qing Zhang (ORCID: https://orcid.org/0000-0001-7370-2829)
- Yong-liang Jia
- Weidong Wu
Institutions
- Zhengzhou University (CN)
- Fifth Affiliated Hospital of Zhengzhou University (CN)
- First Affiliated Hospital of Zhengzhou University (CN)
- The Ohio State University (US)
Publication Details
- Journal
- Biological Procedures Online
- Published
- 2025-05-20
- DOI
- https://doi.org/10.1186/s12575-025-00274-5
- Citations
- 1
- Primary Topic
- CAR-T cell therapy research
- Type
- article
- Field-Weighted Citation Impact
- 1.05
Funders
- Zhengzhou University